This website uses cookies to enhance the user experience.
||
N

NORORTHO AS984 588 267

Purchase and sale
Limited company
C. J. Hambros plass 2 0164 OSLO, Norge
Goods and trade
/ Purchase and sale
/ 46.460 Wholesale of pharmaceutical goods

NORORTHO AS

Operating
Salg av dentalartikler. Det skal være anledning til å eie aksjer og andeler i andre selskaper, samt hva herved naturlig står i forbindelse.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO
KB

Karel Budka1984

Chairman of the board
KB

Karel Budka1984

Years since formation
23 years
since Jun 12, 2002
Type
Limited company
VAT registered
Yes
Number of employees
5

Ownership

Number of shares and share classes
200
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2024
51,171,965
NOK
Annual total result 2024
1,712,639
NOK
Total equity 2024
10,564,079
NOK
Last update: Dec 12, 2025

Management

Management / administration

NameRoleShares
KB

Karel Budka

1984

Managing Director/CEO-

Board

NameRoleShares
KB

Karel Budka

1984

Chairman-
KR

Karel Rajchert

1992

Board Member-

Others

NameRoleShares
G
GRANT THORNTON REVISJON AS
Auditor-
M
MPR REGNSKAP AS
Accountant-
Last update: Jul 4, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
N
NOBEL BIOCARE NORGE AS
Ordinary shares
200
100 %
Last update: Jun 2, 2025

Group structure

  • NOBEL BIOCARE NORGE AS
    Total operating income 2024: NOK 29,828,028
    Operating profit 2024: NOK 804,592
    Employees: 0

Financials

in NOK

Summary

Year2024202320222021
Total operating income
51,171,965
49,225,220
39,744,044
35,231,430
Annual Total Result
1,712,639
1,442,753
532,824
586,648
Total assets
31,591,411
22,445,747
22,090,310
15,570,478
Total liabilities
21,027,332
13,594,308
14,681,623
8,694,616
Total equity
10,564,079
8,851,440
7,408,687
6,875,862

P&L

Year2024202320222021
Total operating income
51,171,965
49,225,220
39,744,044
35,231,430
Total operating costs
48,864,110
45,848,717
38,795,972
34,124,721
Operating result
2,307,855
3,376,503
948,072
1,106,709
Financial income/costs
5,532
-1,436,208
-200,313
-332,022
Profit before tax
2,313,388
1,940,295
747,759
774,687
Total tax & extraordinary income/cost
600,749
497,542
214,935
188,039
Annual Total Result
1,712,639
1,442,753
532,824
586,648

Balance overview

Year2024202320222021
Total fixed assets
53,328
49,195
37,477
26,998
Total current assets
31,538,083
22,396,552
22,052,833
15,543,480
Total assets
31,591,411
22,445,747
22,090,310
15,570,478
Short term debt
21,027,332
13,594,308
14,681,623
8,694,616
Long term debt
0
0
0
0
Total liabilities
21,027,332
13,594,308
14,681,623
8,694,616
Contributed capital
200,000
200,000
200,000
200,000
Retained earnings
10,364,079
8,651,440
7,208,687
6,675,862
Total equity
10,564,079
8,851,440
7,408,687
6,875,862
Total equity and liabilities
31,591,411
22,445,748
22,090,310
15,570,478

Classification

21st company classification
BETA
Small company
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods